258 related articles for article (PubMed ID: 20351748)
1. Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.
Bhat KP; Truax AD; Brooks JK; Greer SF
Immunol Cell Biol; 2010; 88(8):807-16. PubMed ID: 20351748
[TBL] [Abstract][Full Text] [Related]
2. The 19S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription.
Bhat KP; Turner JD; Myers SE; Cape AD; Ting JP; Greer SF
Mol Immunol; 2008 Apr; 45(8):2214-24. PubMed ID: 18215421
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.
Bhat KP; Truax AD; Greer SF
J Biol Chem; 2010 Aug; 285(34):25893-903. PubMed ID: 20538595
[TBL] [Abstract][Full Text] [Related]
4. The 19S ATPase S6a (S6'/TBP1) regulates the transcription initiation of class II transactivator.
Truax AD; Koues OI; Mentel MK; Greer SF
J Mol Biol; 2010 Jan; 395(2):254-69. PubMed ID: 19853614
[TBL] [Abstract][Full Text] [Related]
5. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V
PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568
[TBL] [Abstract][Full Text] [Related]
6. Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.
Inostroza-Nieves Y; Venkatraman P; Zavala-Ruiz Z
Immunol Lett; 2012 Sep; 147(1-2):67-74. PubMed ID: 22771340
[TBL] [Abstract][Full Text] [Related]
7. N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
Schnappauf F; Hake SB; Camacho Carvajal MM; Bontron S; Lisowska-Grospierre B; Steimle V
Eur J Immunol; 2003 Aug; 33(8):2337-47. PubMed ID: 12884309
[TBL] [Abstract][Full Text] [Related]
8. Regulation of acetylation at the major histocompatibility complex class II proximal promoter by the 19S proteasomal ATPase Sug1.
Koues OI; Dudley RK; Truax AD; Gerhardt D; Bhat KP; McNeal S; Greer SF
Mol Cell Biol; 2008 Oct; 28(19):5837-50. PubMed ID: 18662994
[TBL] [Abstract][Full Text] [Related]
9. The 19S proteasome positively regulates histone methylation at cytokine inducible genes.
Koues OI; Dudley RK; Mehta NT; Greer SF
Biochim Biophys Acta; 2009; 1789(11-12):691-701. PubMed ID: 19660582
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
11. FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.
Kasuga Y; Ouda R; Watanabe M; Sun X; Kimura M; Hatakeyama S; Kobayashi KS
Proc Natl Acad Sci U S A; 2023 Jun; 120(24):e2218955120. PubMed ID: 37279268
[TBL] [Abstract][Full Text] [Related]
12. The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.
Mudhasani R; Fontes JD
Mol Cell Biol; 2002 Jul; 22(14):5019-26. PubMed ID: 12077331
[TBL] [Abstract][Full Text] [Related]
13. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
[TBL] [Abstract][Full Text] [Related]
14. ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription.
Al-Kandari W; Jambunathan S; Navalgund V; Koneni R; Freer M; Parimi N; Mudhasani R; Fontes JD
Mol Immunol; 2007 Jan; 44(4):311-21. PubMed ID: 16600381
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of CIITA transcriptional function by ubiquitin.
Greer SF; Zika E; Conti B; Zhu XS; Ting JP
Nat Immunol; 2003 Nov; 4(11):1074-82. PubMed ID: 14528304
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5'-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes.
van der Stoep N; Quinten E; van den Elsen PJ
J Immunol; 2002 Nov; 169(9):5061-71. PubMed ID: 12391222
[TBL] [Abstract][Full Text] [Related]
17. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells.
Fang M; Xia J; Wu X; Kong H; Wang H; Xie W; Xu Y
Eur J Immunol; 2013 Aug; 43(8):2162-73. PubMed ID: 23681904
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
19. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
20. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
